138 related articles for article (PubMed ID: 37742585)
1. The impact of COVID-19 public health measures on attendance and overdose at supervised injecting facilities in Australia.
Roxburgh A; Livingston M; Dietze P; Nielsen S; Cogger S; Bartlett M; Day C; Latimer J; Jauncey M; Clark N
Public Health; 2023 Nov; 224():90-97. PubMed ID: 37742585
[TBL] [Abstract][Full Text] [Related]
2. The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia.
Salmon AM; van Beek I; Amin J; Kaldor J; Maher L
Addiction; 2010 Apr; 105(4):676-83. PubMed ID: 20148794
[TBL] [Abstract][Full Text] [Related]
3. Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia.
Roxburgh A; Jauncey M; Day C; Bartlett M; Cogger S; Dietze P; Nielsen S; Latimer J; Clark N
Harm Reduct J; 2021 Feb; 18(1):20. PubMed ID: 33596940
[TBL] [Abstract][Full Text] [Related]
4. Estimated impact of supervised injection facilities on overdose fatalities and healthcare costs in New York City.
Behrends CN; Paone D; Nolan ML; Tuazon E; Murphy SM; Kapadia SN; Jeng PJ; Bayoumi AM; Kunins HV; Schackman BR
J Subst Abuse Treat; 2019 Nov; 106():79-88. PubMed ID: 31540615
[TBL] [Abstract][Full Text] [Related]
5. A snapshot of injecting drug consumption from the analysis of used syringes within the Medically Supervised Injecting Centre in Sydney, Australia.
Fursman H; Finch E; Xiao L; Lefrançois E; Gupta A; Bartlett M; Latimer J; Chadwick S; Roux C; Morelato M
Drug Alcohol Rev; 2024 Mar; 43(3):787-798. PubMed ID: 38145366
[TBL] [Abstract][Full Text] [Related]
6. Health literacy and changes in pattern of drug use among participants at the Stockholm Needle Exchange Program during the COVID-19 pandemic.
Lindqvist K; Wallmofeldt C; Holmén E; Hammarberg A; Kåberg M
Harm Reduct J; 2021 May; 18(1):52. PubMed ID: 33971892
[TBL] [Abstract][Full Text] [Related]
7. Supervised injection facility use and all-cause mortality among people who inject drugs in Vancouver, Canada: A cohort study.
Kennedy MC; Hayashi K; Milloy MJ; Wood E; Kerr T
PLoS Med; 2019 Nov; 16(11):e1002964. PubMed ID: 31770391
[TBL] [Abstract][Full Text] [Related]
8. Shooting gallery operation in the context of establishing a medically supervised injecting center: Sydney, Australia.
Kimber J; Dolan K
J Urban Health; 2007 Mar; 84(2):255-66. PubMed ID: 17273925
[TBL] [Abstract][Full Text] [Related]
9. Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study.
Bouvier BA; Elston B; Hadland SE; Green TC; Marshall BD
Harm Reduct J; 2017 Feb; 14(1):13. PubMed ID: 28219388
[TBL] [Abstract][Full Text] [Related]
10. Changes in supervised consumption site use and emergency interventions in Montréal, Canada in the first twelve months of the COVID-19 pandemic: An interrupted time series study.
Zolopa C; Brothers TD; Leclerc P; Mary JF; Morissette C; Bruneau J; Hyshka E; Martin NK; Larney S
Int J Drug Policy; 2022 Dec; 110():103894. PubMed ID: 36308892
[TBL] [Abstract][Full Text] [Related]
11. Monitoring for fentanyl within Australian supervised injecting facilities: Findings from feasibility testing of novel methods and collaborative workshops.
Nielsen S; Barratt M; Hiley S; Bartlett M; Latimer J; Jauncey M; Roux C; Morelato M; Clark N; Kowalski M; Gilbert M; Francia L; Shipton A; Gerostamoulos D; Glowacki L; Lam T
Int J Drug Policy; 2023 May; 115():104015. PubMed ID: 37043848
[TBL] [Abstract][Full Text] [Related]
12. Infrequent detection of unintentional fentanyl use via urinalysis among people who regularly inject opioids in Sydney and Melbourne, Australia.
Lam T; Barratt MJ; Bartlett M; Latimer J; Jauncey M; Hiley S; Clark N; Gerostamoulos D; Glowacki L; Roux C; Morelato M; Nielsen S
Addiction; 2022 Aug; 117(8):2331-2337. PubMed ID: 35129225
[TBL] [Abstract][Full Text] [Related]
13. The projected costs and benefits of a supervised injection facility in Seattle, WA, USA.
Hood JE; Behrends CN; Irwin A; Schackman BR; Chan D; Hartfield K; Hess J; Banta-Green C; Whiteside L; Finegood B; Duchin J
Int J Drug Policy; 2019 May; 67():9-18. PubMed ID: 30802842
[TBL] [Abstract][Full Text] [Related]
14. Substances injected at the Sydney supervised injecting facility: A chemical analysis of used injecting equipment and comparison with self-reported drug type.
Lefrancois E; Belackova V; Silins E; Latimer J; Jauncey M; Shimmon R; Mozaner Bordin D; Augsburger M; Esseiva P; Roux C; Morelato M
Drug Alcohol Depend; 2020 Apr; 209():107909. PubMed ID: 32145660
[TBL] [Abstract][Full Text] [Related]
15. Changing risk and presentation of overdose associated with consumption of street drugs at a supervised injection site in Vancouver, Canada.
Notta D; Black B; Chu T; Joe R; Lysyshyn M
Drug Alcohol Depend; 2019 Mar; 196():46-50. PubMed ID: 30665151
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada.
Karamouzian M; Dohoo C; Forsting S; McNeil R; Kerr T; Lysyshyn M
Harm Reduct J; 2018 Sep; 15(1):46. PubMed ID: 30200991
[TBL] [Abstract][Full Text] [Related]
17. My place, your place, or a safer place: the intention among Montréal injecting drug users to use supervised injecting facilities.
Green TC; Hankins CA; Palmer D; Boivin JF; Platt R
Can J Public Health; 2004; 95(2):110-4. PubMed ID: 15074900
[TBL] [Abstract][Full Text] [Related]
18. The willingness of people who inject drugs in Boston to use a supervised injection facility.
León C; Cardoso L; Mackin S; Bock B; Gaeta JM
Subst Abus; 2018 Jan; 39(1):95-101. PubMed ID: 28799847
[TBL] [Abstract][Full Text] [Related]
19. Mitigating the heroin crisis in Baltimore, MD, USA: a cost-benefit analysis of a hypothetical supervised injection facility.
Irwin A; Jozaghi E; Weir BW; Allen ST; Lindsay A; Sherman SG
Harm Reduct J; 2017 May; 14(1):29. PubMed ID: 28532488
[TBL] [Abstract][Full Text] [Related]
20. Perspectives on supervised injection facilities among service industry employees in New York City: A qualitative exploration.
Wolfson-Stofko B; Elliott L; Bennett AS; Curtis R; Gwadz M
Int J Drug Policy; 2018 Dec; 62():67-73. PubMed ID: 30359875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
